Analysis of drug metabolism activities in a miniaturized liver cell bioreactor for use in pharmacological studies
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Based on a hollow fiber perfusion technology with internal oxygenation, a miniaturized bioreactor with a volume of 0.5 mL for in vitro studies was recently developed. Here, the suitability of this novel culture system for pharmacological studies was investigated, focusing on the model drug diclofenac. Primary human liver cells were cultivated in bioreactors and in conventional monolayer cultures in parallel over 10 days. From day 3 on, diclofenac was continuously applied at a therapeutic concentration (6.4 µM) for analysis of its metabolism. In addition, the activity and gene expression of the cytochrome P450 (CYP) isoforms CYP1A2, CYP2B6, CYP2C9, CYP2D6, and CYP3A4 were assessed. Diclofenac was metabolized in bioreactor cultures with an initial conversion rate of 230 ± 57 pmol/h/10 6 cells followed by a period of stable conversion of about 100 pmol/h/10 6 cells. All CYP activities tested were maintained until day 10 of bioreactor culture. The expression of corresponding mRNAs correlated well with the degree of preservation. Immunohistochemical characterization showed the formation of neo‐tissue with expression of CYP2C9 and CYP3A4 and the drug transporters breast cancer resistance protein (BCRP) and multidrug resistance protein 2 (MRP2) in the bioreactor. In contrast, monolayer cultures showed a rapid decline of diclofenac conversion and cells had largely lost activity and mRNA expression of the assessed CYP isoforms at the end of the culture period. In conclusion, diclofenac metabolism, CYP activities and gene expression levels were considerably more stable in bioreactor cultures, making the novel bioreactor a useful tool for pharmacological or toxicological investigations requiring a highly physiological in vitro representation of the liver. Biotechnol. Bioeng. 2012; 109: 3172–3181. © 2012 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rodríguez-Antona, C., Donato, M. T., Boobis, A., Edwards, R. J., Watts, P. S., Castell, J. V., & Gómez-Lechón, M.-J. (2002) · Xenobiotica · doi:10.1080/00498250210128675 · Cited by 420
Cited by
Lauschke, V. M., Hendriks, D. F. G., Bell, C. C., Andersson, T. B., & Ingelman-Sundberg, M. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00150 · Cited by 241
Self-citationCell sources for in vitro human liver cell culture models
Zeilinger, K., Freyer, N., Damm, G., Seehofer, D., & Knöspel, F. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216657448 · Cited by 230
“Evaluation Figure 3 Miniaturized four-compartment bioreactor for high-density perfusion culture of liver cells.(66) The bioreactor technology is based on two or more layers of hollow-fiber capillaries, which serve for counter-current medium perfusion (marked in red and blue) and air/CO2 supply (yellow).”
BackgroundSelf-citationA critical perspective on 3D liver models for drug metabolism and toxicology studies
Serras, A. S., Rodrigues, J. S., Cipriano, M., Rodrigues, A. V., Oliveira, N. G., & Miranda, J. P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.626805 · Cited by 138
Immune-mediated drug-induced liver injury: immunogenetics and experimental models
Gerussi, A., Natalini, A., Antonangeli, F., Mancuso, C., Agostinetto, E., Barisani, D., Di Rosa, F., Andrade, R., & Invernizzi, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094557 · Cited by 87
“In some cases, even vascular- and bile canaliculi-like structures have been observed [145,146].”
BackgroundZhou, Y., Shen, J. X., & Lauschke, V. M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01093 · Cited by 85
Kammerer, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910214 · Cited by 59
“This resulted in a culture medium reduction to 8 mL or 2 mL without further downregulation of albumin [120,121] and urea synthesis, and also MRP2 and Pgp expression were sustained [121].”
Background3D Cultivation Techniques for Primary Human Hepatocytes
Bachmann, A., Moll, M., Gottwald, E., Nies, C., Zantl, R., Wagner, H., Burkhardt, B., Sánchez, J., Ladurner, R., Thasler, W., et al. (2015) · Microarrays · doi:10.3390/microarrays4010064 · Cited by 59
“5 mL medium and 20 million cells [65].”
BackgroundSelf-citationDeharde, D., Schneider, C., Hiller, T., Fischer, N., Kegel, V., Lübberstedt, M., Freyer, N., Hengstler, J. G., Andersson, T. B., Seehofer, D., et al. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1758-z · Cited by 58
Self-citationEpigenetic Modifications of the Liver Tumor Cell Line HepG2 Increase Their Drug Metabolic Capacity
Ruoß, M., Damm, G., Vosough, M., Ehret, L., Grom-Baumgarten, C., Petkov, M., Naddalin, S., Ladurner, R., Seehofer, D., Nussler, A., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020347 · Cited by 37
“The enzymatic activity was measured by the company Pharmacelsus, Saarbrücken, Germany using a LC/MS based methodology [17,43].”
MethodSelf-citationLu, J., Zhu, D., & Li, L. (2022) · The International Journal of Artificial Organs · doi:10.1177/03913988211066502 · Cited by 3
Metadata
- Authors
- Hoffmann, S. A., Müller‐Vieira, U., Biemel, K., Knobeloch, D., Heydel, S., Lübberstedt, M., Nüssler, A. K., Andersson, T. B., Gerlach, J. C., & Zeilinger, K.
- Venue
- Biotechnology and Bioengineering
- Publisher
- Wiley
- Published
- 2012-06-27
- Volume
- 109
- Issue
- 12
- Pages
- 3172-3181
- ISSN
- 0006-3592 (ISSN-L)
- 1097-0290
- OpenAlex
- W2067959462
- Cited by
- 69
- References
- 1
- FWCI
- 5.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.